C-ERB-B2 expression as a predictor of outcome in a randomized trial comparing adjuvant CMF vs single-agent epirubicin in stage I-II breast cancer (BC) patients

✍ Scribed by M. Colozza; S. Gori; A.M. Mosconi; E. Bucciarelli; G. Bisagni; C. Rodinò; A.Rosa Bian; R. Sabbatini; Mazzocchi

• Book ID: 117667269
• Publisher: Elsevier Science
• Year: 1999
• Tongue: English
• Weight: 120 KB
• Volume: 35
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(99)80719-9